期刊文献+

Epithelial markers of colorectal carcinogenesis in ulcerative colitis and primary sclerosing cholangitis 被引量:2

Epithelial markers of colorectal carcinogenesis in ulcerative colitis and primary sclerosing cholangitis
下载PDF
导出
摘要 AIM:To evaluate the expression of epithelial markers of colorectal carcinogenesis in patients with long-term ulcerative colitis(UC) and primary sclerosing cholangitis(PSC) before and after transplantation.METHODS:Eight patients with UC and PSC prior to liver transplantation(PSC-UC),22 patients with UC after liver transplantation for PSC(OLT),9 patients with active ulcerative colitis without PSC(UCA),7 patients withUC in remission(UCR) and 10 controls(N) underwent colonoscopy with multiple biopsies.Specimens were analysed histologically and semi-quantitatively immunohistochemically for p53,Bcl-2 and cyclooxygenase-2(COX-2) markers.Statistical analysis was performed by Kruskal-Wallis and Fisher's exact tests.RESULTS:PSC-UC had a statistically significantly higher expression of p53 in the nondysplastic mucosa as compared to OLT,UCA,UCR and N(P < 0.05).We also found a statistically significant positive correlation between the incidence of PSC and the expression of p53(P < 0.001).UCA had a higher p53 expression as compared to UCR.OLT had a significantly lower expression of p53 as compared with PSC-UC(P < 0.001).Bcl-2 had a significant higher bcl-2 expression as compared with controls.No difference in COX-2 expression between PSC-UC,UCR and UCA was found.UCA had higher COX-2 expression as compared to UCR.We also found a statistically significant positive correlation between the expression of COX-2 and p53.Patients after liver transplantation for PSC had a statistically significantly lower expression of the p53 compared with PSCUC(P < 0.001).PSC-UC had the same inflammatory endoscopic activity as OLT and UCR when evaluated with the Mayo score.CONCLUSION:Our study shows that the nondysplatic mucosa of UC patients with PSC is characterised by a higher expression of the tumour suppressor gene p53,suggesting a higher susceptibility of cancer.This p53 overexpression correlates with the presence of PSC whilst it is not present in patients with UC after liver transplantation for PSC. AIM: To evaluate the expression of epithelial markers of colorectal carcinogenesis in patients with long-term ulcerative colitis (UC) and primary sclerosing cholangitis (PSC) before and after transplantation. METHODS: Eight patients with UC and PSC prior to liver transplantation (PSC-UC), 22 patients with UC after liver transplantation for PSC (OLT), 9 patients with active ulcerative colitis without PSC (UCA), 7 patients with UC in remission (UCR) and 10 controls (N) underwent colonoscopy with multiple biopsies. Specimens were analysed histologically and semi-quantitatively immunohistochemically for p53, Bcl-2 and cyclooxygenase-2 (COX-2) markers. Statistical analysis was performed by Kruskal-Wallis and Fisher’s exact tests. RESULTS: PSC-UC had a statistically significantly higher expression of p53 in the nondysplastic mucosa as compared to OLT, UCA, UCR and N (P < 0.05). We also found a statistically significant positive correlation between the incidence of PSC and the expression of p53 (P < 0.001). UCA had a higher p53 expression as compared to UCR. OLT had a significantly lower expression of p53 as compared with PSC-UC (P < 0.001). Bcl-2 had a significant higher bcl-2 expression as compared with controls. No difference in COX-2 expression between PSC-UC, UCR and UCA was found. UCA had higher COX-2 expression as compared to UCR. We also found a statistically significant positive correlation between the expression of COX-2 and p53. Patients after liver transplantation for PSC had a statistically significantly lower expression of the p53 compared with PSC-UC (P < 0.001). PSC-UC had the same inflammatory endoscopic activity as OLT and UCR when evaluated with the Mayo score. CONCLUSION: Our study shows that the nondysplatic mucosa of UC patients with PSC is characterised by a higher expression of the tumour suppressor gene p53, suggesting a higher susceptibility of cancer. This p53 overexpression correlates with the presence of PSC whilst it is not present in patients with UC after liver transplantation for PSC.
出处 《World Journal of Gastroenterology》 SCIE CAS 2013年第14期2234-2241,共8页 世界胃肠病学杂志(英文版)
基金 Supported by IGA Ministry of Health,Czech Republic,No.7878/3
关键词 Imunohistochemistry ULCERATIVE COLITIS Primary SCLEROSING CHOLANGITIS Colorectal carcinoma Liver transplantation p53 BCL2 CYCLOOXYGENASE-2 Imunohistochemistry Ulcerative colitis Primary sclerosing cholangitis Colorectal carcinoma Liver transplantation p53 bcl2 Cyclooxygenase-2
  • 相关文献

参考文献6

  • 1Carsten Gnewuch,Gerhard Liebisch,Thomas Langmann,Benjamin Dieplinger,Thomas Mueller,Meinhard Haltmayer,Hans Dieplinger,Alexandra Zahn,Wolfgang Stremmel,Gerhard Rogler,Gerd Schmitz.Serum bile acid profiling reflects enterohepatic detoxification state and intestinal barrier function in inlammatory bowel disease[J].World Journal of Gastroenterology,2009,15(25):3134-3141. 被引量:4
  • 2Harry Sokol,Jacques Cosnes,Olivier Chazouilleres,Laurent Beaugerie,Emmanuel Tiret,Raoul Poupon,Philippe Seksik.Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis[J].World Journal of Gastroenterology,2008,14(22):3497-3503. 被引量:10
  • 3Davy Carlos Mendes Rapozo,Ana Braunstein Grinmann,Ana Teresa Pugas Carvalho,Heitor Siffert P. Souza,Sheila Coelho Soares-Lima,Tatiana Almeida Sim?o,Daurita Paiva,Flávio Abby,Rodolpho Mattos Albano,Luiz Felipe Ribeiro Pinto.Analysis of mutations in TP53, APC, K-ras, and DCC genes in the non-dysplastic mucosa of patients with inflammatory bowel disease[J].International Journal of Colorectal Disease.2009(10)
  • 4Canan Alkim,Berna Savas,Arzu Ensari,Huseyin Alkim,Ulku Dagli,Erkan Parlak,Aysel Ulker,Burhan Sahin.Expression of p53, VEGF, Microvessel Density, and Cyclin-D1 in Noncancerous Tissue of Inflammatory Bowel Disease[J].Digestive Diseases and Sciences.2009(9)
  • 5A. R. MacLean M.D.Outcome of Patients Undergoing Liver Transplantation for Primary Sclerosing Cholangitis[J].Diseases of the Colon & Rectum.2003(8)
  • 6Steven A. Ahrendt,Asif Rashid,John T. Chow,Claus F. Eisenberger,Henry A. Pitt,David Sidransky.p53 overexpression and K-ras gene mutations in primary sclerosing cholangitis-associated biliary tract cancer[J].Journal of Hepato - Biliary - Pancreatic Surgery.2000(4)

二级参考文献38

  • 1Silvio Danese,Stefano Semeraro,Alfredo Papa,Italia Roberto,Franco Scaldaferri,Giuseppe Fedeli,Giovanni Gasbarrini,Antonio Gasbarrini.Extraintestinal manifestations in inflammatory bowel disease[J].World Journal of Gastroenterology,2005,11(46):7227-7236. 被引量:25
  • 2Annika Lapidus,Jan-Erikkerlund,Curt Einarsson.Gallbladder bile composition in patients with Crohn's disease[J].World Journal of Gastroenterology,2006,12(1):70-74. 被引量:3
  • 3[1]Smith MP,Loe RH.Sclerosing Cholangitis; Review of Recent Case Reports And Associated Diseases And Four New Cases.Am J Surg 1965; 110:239-246
  • 4[2]Atkinson AJ,Carroll WW.Sclerosing Cholangitis.Association With Regional Enteritis.Jama 1964; 188:183-184
  • 5[3]Aadland E,Schrumpf E,Fausa O,Elgjo K,Heilo A,Aakhus T,Gjone E.Primary sclerosing cholangitis:a long-term follow-up study.Scand J Gastroenterol 1987; 22:655-664
  • 6[4]Chapman RW,Arborgh BA,Rhodes JM,Summerfield JA,Dick R,Scheuer PJ,Sherlock S.Primary sclerosing cholangitis:a review of its clinical features,cholangiography,and hepatic histology.Gut 1980; 21:870-877
  • 7[5]Fausa O,Schrumpf E,Elgjo K.Relationship of inflammatory bowel disease and primary sclerosing cholangitis.Semin Liver Dis 1991; 11:31-39
  • 8[6]Riley TR,Schoen RE,Lee RG,Rakela J.A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease.Am J Gastroenterol 1997; 92:279-282
  • 9[7]Wiesner RH,LaRusso NF.Clinicopathologic features of the syndrome of primary sclerosing cholangitis.Gastroenterology 1980; 79:200-206
  • 10[8]Loftus EV Jr,Harewood GC,Loftus CG,Tremaine WJ,Harmsen WS,Zinsmeister AR,Jewell DA,Sandborn WJ.PSC-IBD:a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis.Gut 2005; 54:91-96

共引文献12

同被引文献11

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部